{"id":68745,"date":"2026-02-20T17:22:38","date_gmt":"2026-02-20T17:22:38","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68745"},"modified":"2026-10-15T10:34:00","modified_gmt":"2026-10-15T10:34:00","slug":"bpc-157","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/bpc-157\/","title":{"rendered":"BPC-157"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 BPC-157?<\/h3>\n<p style=\"margin: 0;\"><strong>BPC-157<\/strong> (Body Protection Compound 157) is a 15-amino-acid synthetic pentadecapeptide derived from a protective gastric protein. In published preclinical studies it has shown consistent effects on tendon, ligament, gut, muscle, and vascular tissue recovery via VEGF, nitric oxide, and growth-hormone-receptor signaling. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">137525-51-0<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1419.55 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">P\u00f3 liofilizado (ou conforme fornecido)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC verificado, COA dispon\u00edvel mediante pedido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (frigor\u00edfico) para stock de trabalho; \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, utilizar no prazo de ~30 dias. Proteger da luz. N\u00e3o congelar-descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada) ou \u00e1gua est\u00e9ril para per\u00edodos de utiliza\u00e7\u00e3o mais curtos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O que \u00e9 BPC-157?<\/h2>\n<p><strong>BPC-157<\/strong> \u00e9 a abreviatura de <strong>Body Protection Compound 157<\/strong>, a 15-amino-acid synthetic pentadecapeptide originally isolated as a fragment of a larger protective protein found in human gastric juice. Unlike most peptides it is stable in gastric acid, which has made it a frequent subject of oral-administration studies in rodent models alongside the more common subcutaneous route. BPC-157 is one of the most widely studied healing peptides in the preclinical literature, with published work spanning tendon, ligament, gut barrier, skeletal muscle, bone, and vascular tissue. The peptide sequence is GEPPPGKPADDAGLV, molecular weight approximately 1,419\u00a0Da, empirical formula C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub>. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For a deep-dive on mechanism, published trial detail, and dosing considerations, see our full <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a>. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Tr\u00eas Vias de Cicatriza\u00e7\u00e3o Sobrepostas<\/h2>\n<p>O que diferencia o BPC-157 de pept\u00eddeos de via \u00fanica \u00e9 a sua <strong>atividade simult\u00e2nea em tr\u00eas vias de sinaliza\u00e7\u00e3o distintas<\/strong>, each contributing to the observed tissue-recovery phenotype in published studies:<\/p>\n<ul>\n<li><strong>Angiog\u00e9nese \/ Regula\u00e7\u00e3o positiva do VEGF<\/strong> \u2014 O BPC-157 aumenta a express\u00e3o do recetor 2 do fator de crescimento endotelial vascular (VEGFR2) em tecidos lesionados, promovendo a forma\u00e7\u00e3o de novos capilares. Isto melhora a perfus\u00e3o local nos locais de repara\u00e7\u00e3o, o passo limitante na cicatriza\u00e7\u00e3o de tend\u00f5es, ligamentos e m\u00fasculos.<\/li>\n<li><strong>Via do \u00f3xido n\u00edtrico (NO)<\/strong> \u2014 O BPC-157 aumenta a atividade da \u00f3xido n\u00edtrico sintase endotelial (eNOS) e protege o endot\u00e9lio vascular contra danos oxidativos. Em modelos de roedores com hipertens\u00e3o portal, vasoconstri\u00e7\u00e3o sist\u00e9mica e \u00falceras g\u00e1stricas, este efeito \u00e9 central para a a\u00e7\u00e3o protetora do composto.<\/li>\n<li><strong>Regula\u00e7\u00e3o positiva do recetor da hormona de crescimento<\/strong> \u2014 O BPC-157 aumenta a express\u00e3o do recetor da hormona de crescimento (GHR) em fibroblastos e ten\u00f3citos, potenciando a s\u00edntese de colag\u00e9nio tipo I. Este mecanismo est\u00e1 na base dos ganhos de resist\u00eancia dos tend\u00f5es observados em modelos de sec\u00e7\u00e3o do tend\u00e3o de Aquiles e do ligamento colateral medial.<\/li>\n<\/ul>\n<p>Because these three pathways converge on tissue that has been injured, BPC-157 produces faster and more complete recovery than single-pathway interventions in the same models. It is also notably well tolerated across the range of published doses, with minimal off-target signaling reported in toxicology studies. <\/p>\n<h2>Published Evidence<\/h2>\n<p>BPC-157 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Recupera\u00e7\u00e3o de les\u00f5es de tend\u00f5es e ligamentos<\/strong> \u2014 Modelos de roedores com sec\u00e7\u00e3o do tend\u00e3o de Aquiles, rutura do ligamento colateral medial e rotura do manguito rotador (Chang et al., J Appl Physiol 2011; Staresinic et al., J Orthop Res 2003)<\/li>\n<li><strong>Gut barrier integrity and ulcer studies<\/strong> \u2014 Modelos de \u00falcera g\u00e1strica, colite e doen\u00e7a inflamat\u00f3ria intestinal; a origem g\u00e1strica do BPC-157 \u00e9 mecanicamente relevante aqui (Sikiric et al., Curr Med Chem 2011)<\/li>\n<li><strong>Regenera\u00e7\u00e3o do m\u00fasculo esquel\u00e9tico<\/strong> \u2014 post-injury recovery kinetics, myoblast proliferation, and myotube formation studies<\/li>\n<li><strong>Joint and cartilage studies<\/strong> \u2014 Modelos de roedores com osteoartrite, composi\u00e7\u00e3o da matriz cartilaginosa e inflama\u00e7\u00e3o sinovial<\/li>\n<li><strong>Angiog\u00e9nese vascular<\/strong> \u2014 forma\u00e7\u00e3o de novos capilares e perfus\u00e3o em locais de tecido lesionado<\/li>\n<li><strong>Cicatriza\u00e7\u00e3o \u00f3ssea<\/strong> \u2014 fracture callus formation in osteotomy and bone-defect study models<\/li>\n<li><strong>Comparative recovery<\/strong> \u2014 compara\u00e7\u00e3o com outros p\u00e9ptidos de cicatriza\u00e7\u00e3o, especialmente <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500 (Thymosin Beta-4)<\/a> como o comparador can\u00f3nico de cicatriza\u00e7\u00e3o sist\u00e9mica. Consulte o <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-vs-tb-500-comparison-guide\/\">Compara\u00e7\u00e3o entre BPC-157 e TB-500<\/a> para uma compara\u00e7\u00e3o detalhada.<\/li>\n<\/ul>\n<p>Para um contexto mais amplo sobre o lugar do BPC-157 no panorama dos p\u00e9ptidos de cicatriza\u00e7\u00e3o, consulte <a href=\"https:\/\/medsbase.com\/pt-pt\/best-peptides-for-muscle-recovery\/\">os melhores p\u00e9ptidos para recupera\u00e7\u00e3o muscular<\/a> artigo de agrupamento e <a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu\/\">p\u00e9ptido de cobre GHK-Cu<\/a> as a complementary anti-aging compound. Browse the full <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a> para encontrar compostos relacionados. <\/p>\n<h2>For\u00e7as e Concentra\u00e7\u00f5es Dispon\u00edveis<\/h2>\n<p>A MedsBase disp\u00f5e de BPC-157 nos seguintes tamanhos de frascos liofilizados. Cada varia\u00e7\u00e3o \u00e9 enviada em embalagens de 10, 20 e 30 frascos com orienta\u00e7\u00f5es completas de reconstitui\u00e7\u00e3o:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">For\u00e7a do frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos das embalagens<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, titration<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, most commonly ordered<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended protocols, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection volume in rodent protocols. <\/p>\n<h2>Como Comparar \u2014 BPC-157 vs TB-500<\/h2>\n<p>BPC-157 e <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a> are the two most-cited healing peptides. They are often studied in parallel because they act via complementary, largely non-overlapping mechanisms. Many preclinical protocols combine them rather than using either alone. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">TB-500 (Thymosin Beta-4)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 amino\u00e1cidos (pentadecapept\u00eddeo)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">43 amino\u00e1cidos (pept\u00eddeo t\u00edmico)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mecanismo prim\u00e1rio<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">VEGF + NO + regula\u00e7\u00e3o positiva do recetor de GH<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sequestro de G-actina, migra\u00e7\u00e3o celular<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Distribui\u00e7\u00e3o<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mais localizado no local da inje\u00e7\u00e3o<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sist\u00e9mico, distribui-se amplamente<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013500 mcg, 1\u20132 vezes por dia<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20132,5 mg, 2 vezes por semana<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tend\u00e3o, ligamento, barreira intestinal<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Card\u00edaco, m\u00fasculo sist\u00e9mico, vascular<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Empilhamento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Commonly co-administered with TB-500 in studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Commonly co-administered with BPC-157 in studies<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For a full methodological comparison including dosing protocols and when users pick one over the other, read <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500: qual o p\u00e9ptido de cura para o seu objetivo de recupera\u00e7\u00e3o<\/a>. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene os frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original. O BPC-157 liofilizado \u00e9 est\u00e1vel nestas condi\u00e7\u00f5es at\u00e9 36 meses. Evite ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o no p\u00f3. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> injecte \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco do p\u00e9ptido (n\u00e3o diretamente sobre o bolo liofilizado) de acordo com a tabela de dilui\u00e7\u00e3o acima. Agite suavemente \u2014 n\u00e3o <strong>n\u00e3o<\/strong> agite vigorosamente \u2014 e aguarde 2\u20135 minutos para dissolu\u00e7\u00e3o completa. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda deve ser l\u00edmpida e incolor. <strong>Ap\u00f3s reconstitui\u00e7\u00e3o:<\/strong> armazene refrigerado a 2\u20138 \u00b0C e utilize no prazo de 30 dias para uma estabilidade \u00f3tima. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 os ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o degradam a integridade do p\u00e9ptido. Descarte qualquer frasco que apresente turva\u00e7\u00e3o, precipitado ou descolora\u00e7\u00e3o. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is BPC-157 used for in studies?<\/h3>\n<p>BPC-157 is used in studies investigating tendon and ligament healing, gut barrier integrity, skeletal muscle recovery, vascular angiogenesis, anti-inflammatory signaling, and bone healing. It is <strong>n\u00e3o<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>Como \u00e9 que o BPC-157 difere do TB-500?<\/h3>\n<p>BPC-157 is a 15-amino-acid pentadecapeptide derived from gastric juice, acting mostly locally via VEGF, nitric oxide, and growth-hormone-receptor pathways. TB-500 is a 43-amino-acid thymic peptide that acts systemically via G-actin binding and cell migration. The two are often co-administered in studies because their mechanisms are complementary rather than overlapping. <\/p>\n<h3>What is the typical BPC-157 dose?<\/h3>\n<p>Os protocolos pr\u00e9-cl\u00ednicos publicados utilizam tipicamente 250\u2013500 mcg por administra\u00e7\u00e3o, uma ou duas vezes por dia, em ciclos de 4\u20138 semanas. Um frasco de 5 mg reconstitu\u00eddo com 2,0 mL de \u00e1gua bacteriost\u00e1tica produz 2,5 mg\/mL \u2014 10 marcas numa seringa U-100 equivalem a 250 mcg. <\/p>\n<h3>O BPC-157 \u00e9 aprovado pela FDA?<\/h3>\n<p>No. BPC-157 is not approved by the FDA, EMA, MHRA, or any other regulator for human therapeutic use. <\/p>\n<h3>Como deve ser armazenado o BPC-157?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138\u00a0\u00b0C na embalagem original, est\u00e1veis at\u00e9 36 meses. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138\u00a0\u00b0C, utilizar no prazo de 30 dias. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congela\u00e7\u00e3o e descongela\u00e7\u00e3o degradam o pept\u00eddeo. <\/p>\n<h3>Como devo reconstituir o BPC-157?<\/h3>\n<p>Siga o gr\u00e1fico de refer\u00eancia de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o p\u00f3 liofilizado), agite suavemente e aguarde 2\u20135 minutos para dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> agite o frasco. <\/p>\n<h3>Que dosagens est\u00e3o dispon\u00edveis na MedsBase?<\/h3>\n<p>A MedsBase disponibiliza BPC-157 em frascos liofilizados de 2 mg, 5 mg e 10 mg. Cada concentra\u00e7\u00e3o est\u00e1 dispon\u00edvel em embalagens de 10, 20 ou 30 frascos. Todos os frascos s\u00e3o fornecidos com pureza HPLC superior a 99% e um certificado de an\u00e1lise dispon\u00edvel mediante pedido. <\/p>\n<h3>Can BPC-157 and TB-500 be stacked in studies?<\/h3>\n<p>Yes. BPC-157 and TB-500 are frequently co-administered in preclinical studies because their mechanisms are complementary. BPC-157 acts mostly locally via growth-factor upregulation; TB-500 acts systemically via G-actin binding and cell migration. Combined protocols are described in our <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-vs-tb-500-comparison-guide\/\">guia de compara\u00e7\u00e3o<\/a>. <\/p>\n<h3>Does BPC-157 cause side reported effects?<\/h3>\n<p>Published preclinical studies across rodent species has reported a notably clean safety profile at typical doses, with no consistent off-target signals and good tolerability. Long-term human safety data are not available because human trials have not been completed. <\/p>\n<h3>What is the difference between oral and injectable BPC-157 in studies?<\/h3>\n<p>BPC-157 is unusually stable in gastric acid due to its gastric-juice-derived origin, so oral administration is feasible in rodent protocols (unlike most peptides). Subcutaneous injection remains the most common administration route in the literature because it produces more reproducible plasma concentrations. <\/p>\n<h3>Qual \u00e9 a meia-vida do BPC-157?<\/h3>\n<p>In preclinical studies, BPC-157 has an estimated plasma half-life of approximately 4 hours following subcutaneous administration. Oral route studies in rodent models suggest shorter systemic clearance but sustained local effects within the gastrointestinal tract, attributed to the peptide&#8217;s unusual acid-stability. <\/p>\n<h3>How long does BPC-157 take to show effects in preclinical studies?<\/h3>\n<p>Most preclinical studies using BPC-157 in tendon, ligament, and gut injury models report measurable tissue-level changes within 7\u201314 days. The time-course varies with the study model, injury severity, route of administration, and dose used in the study design. <\/p>\n<h3>Posso encomendar BPC-157 para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia BPC-157 para todo o mundo atrav\u00e9s da nossa rede dedicada de envio de p\u00e9ptidos. As encomendas exclusivas de p\u00e9ptidos qualificam-se para o nosso servi\u00e7o de envio de p\u00e9ptidos aut\u00f3nomo. Todas as encomendas s\u00e3o enviadas em embalagens com controlo de temperatura e com rastreio completo. <\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">Os protocolos de BPC-157 para recupera\u00e7\u00e3o de tend\u00f5es, ligamentos e tecidos moles geralmente combinam-no com TB-500 para efeitos angiog\u00e9nicos e citoesquel\u00e9ticos sin\u00e9rgicos; para o regime combinado, consulte o nosso <a href=\"\/pt-pt\/peptide-healing-stack\/\">Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + \u00e1gua bacteriost\u00e1tica)<\/a> com ambos os frascos liofilizados e \u00e1gua de reconstitui\u00e7\u00e3o numa \u00fanica encomenda com taxa de envio de p\u00e9ptidos de $0.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/pt-pt\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/pt-pt\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agonista selectivo de grelina \u2014 pulso de GH limpo sem cortisol\/prolactina<\/li>\n<li><a href=\"\/pt-pt\/cjc-1295-with-dac\/\"><strong>CJC-1295 com DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH com meia-vida prolongada<\/li>\n<li><a href=\"\/pt-pt\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<li><a href=\"\/pt-pt\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolic \/ regenerative support<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Leia o nosso guia completo baseado em evid\u00eancias: <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-peptide-healing-recovery-guide\/\"><strong>BPC-157 \u2014 mecanismo, dados de ensaios e perspetivas<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Suporta a regenera\u00e7\u00e3o celular<br \/>\n\u2705 Melhora a modela\u00e7\u00e3o tecidular<br \/>\n\u2705 Promove a atividade dos fibroblastos<br \/>\n\u2705 Estimula a sinaliza\u00e7\u00e3o angiog\u00e9nica<br \/>\n\u2705 Melhora a estabilidade da matriz extracelular<\/p>\n<p><strong>BPC-157<\/strong> cont\u00e9m composto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70942,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5440,5430,5441],"class_list":["post-68745","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-bpc-157","product_tag-bpc-157-peptide","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/68745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=68745"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/70942"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=68745"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=68745"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=68745"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=68745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}